Evidence and opportunities of hypothermia in acute ischemic stroke: Clinical trials of systemic versus selective hypothermia
Stroke is the second leading cause of death globally and the third leading cause disability. Acute ischemic stroke (AIS), resulting from occlusion of major vessels in the brain, accounts for approximately 87% of strokes. Despite this large majority, current treatment options for AIS are severely lim...
Main Authors: | Christian Huber, Mitchell Huber, Yuchuan Ding |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2019-01-01
|
Series: | Brain Circulation |
Subjects: | |
Online Access: | http://www.braincirculation.org/article.asp?issn=2394-8108;year=2019;volume=5;issue=4;spage=195;epage=202;aulast=Huber |
Similar Items
-
Experience with therapeutic hypothermia in the treatment of ischemic stroke
by: I E Kalenova, et al.
Published: (2012-06-01) -
Local endovascular infusion and hypothermia in stroke therapy: A systematic review
by: Honglian Duan, et al.
Published: (2019-01-01) -
Temporal limits of therapeutic hypothermia onset in clinical trials for acute ischemic stroke: How early is early enough?
by: Hangil Lee, et al.
Published: (2020-01-01) -
Infusion warm during selective hypothermia in acute ischemic stroke
by: Thomas L Merrill, et al.
Published: (2019-01-01) -
Perspectives on benefit of early and prereperfusion hypothermia by pharmacological approach in stroke
by: Fengwu Li, et al.
Published: (2022-01-01)